Conclusions
Abstract:
Clinical research business in Asia has its inherent strengths, weaknesses, opportunities and threats. In large part, the industry is subject to a number of environmental factors. This last chapter undertakes a detailed environmental analysis, highlighting the key macro-environments such as political, economic, socio-cultural, technological, legal and other environmental factors (PESTLE analysis). This will help in understanding the business environment of the CRO industry in Asian countries.
12.1 PESTLE analysis
Asia is a vast region, and home to almost 50 per cent of the world’s population. While the clinical research business in Asia has its inherent strengths, weaknesses, opportunities and threats, it is predominantly ...
Get Clinical Research in Asia now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
